Bo Ren
Yuan Fang
*
TAIPING ZHANG
The final, formatted version of the article will be published soon.
OPINION article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 |
doi: 10.3389/fimmu.2024.1449912
This article is part of the Research Topic Immune-Checkpoint Inhibitors and Immunometabolic Reprogramming in Cancer Immunotherapy View all articles
Full title: Microbiota-Metabolism-Epigenetics-Immunity Axis in Cancer
Provisionally accepted- Peking Union Medical College Hospital (CAMS), Beijing, China
Keywords: Immunotherapy, microbiota, Metabolism, epigenetics, Hallmarks of cancer
Received: 16 Jun 2024; Accepted: 03 Jul 2024.
Copyright: © 2024 Ren, Fang, Gu, You, ZHANG and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yuan Fang, Peking Union Medical College Hospital (CAMS), Beijing, China
Minzhi Gu, Peking Union Medical College Hospital (CAMS), Beijing, China
Lei You, Peking Union Medical College Hospital (CAMS), Beijing, China
Yupei Zhao, Peking Union Medical College Hospital (CAMS), Beijing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.